544642

- Wakefit Innovations Limited's NRC approved the grant of 4,57,611 Employee Stock Options under the WAKEFIT ESOP-2019 on July 13, 2026. - Each option has an exercise price of Re. 1/- and will vest between 12 months and 5 years from the grant date.

- Trading window closure for designated persons and their immediate relatives from July 01, 2026. - This is ahead of the un-audited financial results for the quarter ended June 30, 2026. - The window will re-open 48 hours post results announcement. - Board Meeting date for results will be intimated later.

- Mirae Asset Mutual Fund acquired 1,875,417 shares (0.57% stake) of Wakefit Innovations Ltd. via open market. - The acquisition, made on June 05, 2026, increased their total shareholding from 4.83% to 5.40%.

- Members of Wakefit Innovations Limited approved the alteration of its Memorandum of Association (MOA) on June 6, 2026. This expands the company's object clauses to include new business areas like chemicals, fertilizers, building materials, and broader home improvement and textile products.

- Shareholders approved the alteration of the Memorandum of Association (MOA) by amending existing object clauses and including new ones via remote e-voting. - The special resolution was passed with an overwhelming majority of 99.9994% votes in favor. - The e-voting period was from May 8, 2026, to June 6, 2026.

Management guided for an aspiration of at least 20% revenue growth for FY27 and plans to add over 80 net COCO store additions. Capex for FY27 is projected at INR120-140 crores, mainly for retail expansion including initial spending on a Jumbo store (first Jumbo store expected in early FY28). ESOP expenses are anticipated to decrease to INR12 crores for FY27. Management indicated that higher input costs and price pass-throughs might constrain margin expansion in the near term, potentially impacting EBITDA margins by 1-2 percentage points if aggressive growth targets are pursued, although no material margin dilution is expected for Q1 FY27. The company is observing positive growth trends in April, driven by its mattress portfolio, expanding furniture and furnishing reach, and entering adjacent categories, while prioritizing market share and customer lifetime value.

On May 26, 2026, Wakefit Innovations Limited allotted 13,64,949 fully paid-up Equity Shares of ₹1/- each to eligible employees/ESOP holders under the Wakefit ESOP-2019 scheme. This allotment increased the company's paid-up equity share capital from ₹32,99,66,749 to ₹33,13,31,698.

Wakefit Innovations Limited's Nomination and Remuneration Committee (NRC) approved the grant of 3,28,342 Employee Stock Options under the WAKEFIT ESOP-2019 on May 23, 2026. The options have an exercise price of Re. 1/- per option, will vest after a minimum of 12 months from the grant date, and are exercisable within one year of vesting.

Wakefit Innovations Limited announced that the audio recording of its Earnings conference call, held on May 22, 2026, is available on the company's website. The call discussed the audited financial results for the quarter and financial year ended March 31, 2026.

Wakefit Innovations reported strong Q4FY26 results. Consolidated Revenue from Operations was ₹343.6 Cr vs ₹302.6 Cr (▲13.5% YoY), Reported EBITDA (excl. Other Income) was ₹36.5 Cr vs ₹6.0 Cr (▲511.1% YoY), and Profit After Tax (PAT) was ₹121.8 Cr vs ₹-26.2 Cr (turned profitable YoY). EBITDA Margin expanded significantly to 10.6% vs 2.0% (▲860bps). Management guided for revenue growth in FY27, driven by mattress portfolio strength and expansion in furniture/furnishings.

Wakefit Innovations Limited's Board of Directors, at its meeting on May 21, 2026, approved the appointment of M/s BMP & Co. LLP as the Secretarial Auditors for a period of five consecutive years, commencing from FY 2026-27 till FY 2030-2031. The appointment is subject to approval by shareholders at the ensuing Annual General Meeting.

Consolidated Revenue ₹3,436.00Mn vs ₹3,026.05Mn (▲13.54% YoY), EBITDA ₹538.52Mn vs ₹144.29Mn (▲273.23% YoY), PAT of ₹1,217.45Mn compared to a loss of ₹261.95Mn in the prior year. EBITDA Margin expanded to 15.67% from 4.77% (▲1090bps). The board also approved the appointment of M/s BMP & Co. LLP as Secretarial Auditors for five years.

Consolidated Revenue ₹343.60 Cr vs ₹302.61 Cr (▲13.55% YoY), EBITDA ₹53.85 Cr vs ₹14.43 Cr (▲273.22% YoY), PAT ₹121.75 Cr vs (₹26.20 Cr) (▲564.62% YoY, swung from loss to profit). EBITDA Margin 15.67% vs 4.77% (▲1090bps). The board also approved the appointment of M/s BMP & Co. LLP as Secretarial Auditors for five years.